BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20631009)

  • 1. Comparison of four prognostic scores in peripheral T-cell lymphoma.
    Gutiérrez-García G; García-Herrera A; Cardesa T; Martínez A; Villamor N; Ghita G; Martínez-Trillos A; Colomo L; Setoain X; Rodríguez S; Giné E; Campo E; López-Guillermo A
    Ann Oncol; 2011 Feb; 22(2):397-404. PubMed ID: 20631009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
    Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
    Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.
    Xu P; Yu D; Wang L; Shen Y; Shen Z; Zhao W
    Ann Hematol; 2015 Feb; 94(2):239-47. PubMed ID: 25193354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores.
    Huh SJ; Oh SY; Lee S; Lee JH; Kim SH; Lee GW; Kim SJ; Kim WS; Lee HS; Jo JC; Kim MJ; Kwon JH; Kim HJ
    Int J Hematol; 2019 Oct; 110(4):438-446. PubMed ID: 31250282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?
    Lin HN; Liu CY; Pai JT; Chang FP; Yang CF; Yu YB; Hsiao LT; Chiou TJ; Liu JH; Gau JP; Tzeng CH; Chen PM; Hong YC
    Blood Cancer J; 2012 Oct; 2(10):e93. PubMed ID: 23064741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.
    López-Guillermo A; Cid J; Salar A; López A; Montalbán C; Castrillo JM; González M; Ribera JM; Brunet S; García-Conde J; Fernández de Sevilla A; Bosch F; Montserrat E
    Ann Oncol; 1998 Aug; 9(8):849-55. PubMed ID: 9789607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
    Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
    Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
    Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
    Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
    Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
    Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Møller MB; Nørgaard P; Johansen P; Ralfkiaer E; Brown Pde N; Hansen PB; Jensen BA; Madsen J; Schöllkopf C; d'Amore F
    Hematol Oncol; 2015 Dec; 33(4):120-8. PubMed ID: 25052551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas.
    Sonnen R; Schmidt WP; Müller-Hermelink HK; Schmitz N
    Br J Haematol; 2005 May; 129(3):366-72. PubMed ID: 15842660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).
    Julamanee J; Kayasut K; Lekhakula A
    J Med Assoc Thai; 2015 Oct; 98(10):950-6. PubMed ID: 26638586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
    Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
    Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of prognostic related factors of elderly patients with T/NK cell lymphoma].
    Wang Y; Qian Y; Wu LL; Zhao BB; Xu PP; Zhao WL; Wang L
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):12-5. PubMed ID: 23597457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).
    Cottereau AS; Becker S; Broussais F; Casasnovas O; Kanoun S; Roques M; Charrier N; Bertrand S; Delarue R; Bonnet C; Hustinx R; Gaulard P; de Leval L; Vera P; Itti E; Mounier N; Haioun C; Tilly H; Meignan M
    Ann Oncol; 2016 Apr; 27(4):719-24. PubMed ID: 26787236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive model for treatment outcomes of peripheral T-cell lymphoma, not otherwise specified, in Taiwanese patients.
    Chen NC; Chang H; Kuo MC; Lin TL; Shih LY; Chuang WY; Kao HW
    J Formos Med Assoc; 2024 Feb; 123(2):188-197. PubMed ID: 37558588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
    Reiser M; Josting A; Soltani M; Staib P; Salzberger B; Diehl V; Engert A
    Leuk Lymphoma; 2002 Apr; 43(4):805-11. PubMed ID: 12153168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.